These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 28389691)
1. Deletion of Adseverin in Osteoclasts Affects Cell Structure But Not Bone Metabolism. Cao Y; Wang Y; Sprangers S; Picavet DI; Glogauer M; McCulloch CA; Everts V Calcif Tissue Int; 2017 Aug; 101(2):207-216. PubMed ID: 28389691 [TBL] [Abstract][Full Text] [Related]
2. Adseverin plays a role in osteoclast differentiation and periodontal disease-mediated bone loss. Jiang H; Wang Y; Viniegra A; Sima C; McCulloch CA; Glogauer M FASEB J; 2015 Jun; 29(6):2281-91. PubMed ID: 25681458 [TBL] [Abstract][Full Text] [Related]
3. Adseverin mediates RANKL-induced osteoclastogenesis by regulating NFATc1. Song MK; Lee ZH; Kim HH Exp Mol Med; 2015 Dec; 47(12):e199. PubMed ID: 26642432 [TBL] [Abstract][Full Text] [Related]
4. RARγ is a negative regulator of osteoclastogenesis. Green AC; Poulton IJ; Vrahnas C; Häusler KD; Walkley CR; Wu JY; Martin TJ; Gillespie MT; Chandraratna RA; Quinn JM; Sims NA; Purton LE J Steroid Biochem Mol Biol; 2015 Jun; 150():46-53. PubMed ID: 25800721 [TBL] [Abstract][Full Text] [Related]
5. Polyphosphoinositides-dependent regulation of the osteoclast actin cytoskeleton and bone resorption. Biswas RS; Baker D; Hruska KA; Chellaiah MA BMC Cell Biol; 2004 May; 5():19. PubMed ID: 15142256 [TBL] [Abstract][Full Text] [Related]
6. Osteoclast differentiation and function in aquaglyceroporin AQP9-null mice. Liu Y; Song L; Wang Y; Rojek A; Nielsen S; Agre P; Carbrey JM Biol Cell; 2009 Mar; 101(3):133-40. PubMed ID: 18666888 [TBL] [Abstract][Full Text] [Related]
7. The actin binding protein adseverin regulates osteoclastogenesis. Hassanpour S; Jiang H; Wang Y; Kuiper JW; Glogauer M PLoS One; 2014; 9(9):e109078. PubMed ID: 25275604 [TBL] [Abstract][Full Text] [Related]
8. p130Cas, Crk-associated substrate, plays important roles in osteoclastic bone resorption. Nagai Y; Osawa K; Fukushima H; Tamura Y; Aoki K; Ohya K; Yasuda H; Hikiji H; Takahashi M; Seta Y; Seo S; Kurokawa M; Kato S; Honda H; Nakamura I; Maki K; Jimi E J Bone Miner Res; 2013 Dec; 28(12):2449-62. PubMed ID: 23526406 [TBL] [Abstract][Full Text] [Related]
9. Pin1 regulates osteoclast fusion through suppression of the master regulator of cell fusion DC-STAMP. Islam R; Bae HS; Yoon WJ; Woo KM; Baek JH; Kim HH; Uchida T; Ryoo HM J Cell Physiol; 2014 Dec; 229(12):2166-74. PubMed ID: 24891219 [TBL] [Abstract][Full Text] [Related]
10. Adenosine A(1) receptors regulate bone resorption in mice: adenosine A(1) receptor blockade or deletion increases bone density and prevents ovariectomy-induced bone loss in adenosine A(1) receptor-knockout mice. Kara FM; Doty SB; Boskey A; Goldring S; Zaidi M; Fredholm BB; Cronstein BN Arthritis Rheum; 2010 Feb; 62(2):534-41. PubMed ID: 20112380 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of osteoclast bone resorption activity through osteoprotegerin-induced damage of the sealing zone. Song R; Gu J; Liu X; Zhu J; Wang Q; Gao Q; Zhang J; Cheng L; Tong X; Qi X; Yuan Y; Liu Z Int J Mol Med; 2014 Sep; 34(3):856-62. PubMed ID: 25017214 [TBL] [Abstract][Full Text] [Related]
12. Thyroid-stimulating hormone maintains bone mass and strength by suppressing osteoclast differentiation. Zhang W; Zhang Y; Liu Y; Wang J; Gao L; Yu C; Yan H; Zhao J; Xu J J Biomech; 2014 Apr; 47(6):1307-14. PubMed ID: 24629929 [TBL] [Abstract][Full Text] [Related]
13. Deletion of histone deacetylase 7 in osteoclasts decreases bone mass in mice by interactions with MITF. Stemig M; Astelford K; Emery A; Cho JJ; Allen B; Huang TH; Gopalakrishnan R; Mansky KC; Jensen ED PLoS One; 2015; 10(4):e0123843. PubMed ID: 25875108 [TBL] [Abstract][Full Text] [Related]
14. Hem1 is essential for ruffled border formation in osteoclasts and efficient bone resorption. Werbenko E; de Gorter DJJ; Kleimann S; Beckmann D; Waltereit-Kracke V; Reinhardt J; Geers F; Paruzel P; Hansen U; Pap T; Stradal TEB; Dankbar B Sci Rep; 2024 Apr; 14(1):8109. PubMed ID: 38582757 [TBL] [Abstract][Full Text] [Related]
15. Effects of osteoprotegerin administration on osteoclast differentiation and trabecular bone structure in osteoprotegerin-deficient mice. Yamazaki H; Sasaki T J Electron Microsc (Tokyo); 2005 Oct; 54(5):467-77. PubMed ID: 16339792 [TBL] [Abstract][Full Text] [Related]
16. The Foreign Body Giant Cell Cannot Resorb Bone, But Dissolves Hydroxyapatite Like Osteoclasts. ten Harkel B; Schoenmaker T; Picavet DI; Davison NL; de Vries TJ; Everts V PLoS One; 2015; 10(10):e0139564. PubMed ID: 26426806 [TBL] [Abstract][Full Text] [Related]
17. Calcium regulation of gelsolin and adseverin: a natural test of the helix latch hypothesis. Lueck A; Yin HL; Kwiatkowski DJ; Allen PG Biochemistry; 2000 May; 39(18):5274-9. PubMed ID: 10819996 [TBL] [Abstract][Full Text] [Related]
18. Transgenic overexpression of tartrate-resistant acid phosphatase is associated with induction of osteoblast gene expression and increased cortical bone mineral content and density. Gradin P; Hollberg K; Cassady AI; Lång P; Andersson G Cells Tissues Organs; 2012; 196(1):68-81. PubMed ID: 22248481 [TBL] [Abstract][Full Text] [Related]
19. Cholesterol-sensing receptors, liver X receptor alpha and beta, have novel and distinct roles in osteoclast differentiation and activation. Robertson KM; Norgård M; Windahl SH; Hultenby K; Ohlsson C; Andersson G; Gustafsson JA J Bone Miner Res; 2006 Aug; 21(8):1276-87. PubMed ID: 16869726 [TBL] [Abstract][Full Text] [Related]
20. Effect of CD44 deficiency on in vitro and in vivo osteoclast formation. de Vries TJ; Schoenmaker T; Beertsen W; van der Neut R; Everts V J Cell Biochem; 2005 Apr; 94(5):954-66. PubMed ID: 15578568 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]